Standard Biotools Inc (LAB) financials
Standard Biotools revenue and earnings by year
Standard Biotools's revenue was $85.3 million in the fiscal year to December 31, 2025, down 6.2% from the year before. Net income was -$74.9 million, -87.8% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 2.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85 | 91 | 106 | 98 | 131 | 138 | 117 | 113 | 102 | 104 |
| Revenue growth | -6.2% | -14.4% | 8.6% | -25.0% | -5.5% | 17.8% | 3.8% | 10.8% | -2.4% | — |
| Gross profit | 43 | 45 | 50 | 37 | 69 | 83 | 64 | 62 | 52 | 58 |
| Gross margin | 49.9% | 49.3% | 47.4% | 37.8% | 53.1% | 60.3% | 54.8% | 54.6% | 51.0% | 55.9% |
| Operating income | -110 | -127 | -77 | -116 | -67 | -51 | -52 | -48 | -58 | -73 |
| Operating margin | -129.2% | -140.1% | -72.0% | -118.6% | -51.7% | -36.9% | -44.2% | -42.6% | -57.3% | -70.1% |
| Net income | -75 | -139 | -75 | -190 | -59 | -53 | -65 | -59 | -61 | -76 |
| Net margin | -87.8% | -152.6% | -70.2% | -194.1% | -45.4% | -38.4% | -55.3% | -52.2% | -59.4% | -72.8% |
| Diluted EPS | -$0.20 | -$0.52 | -$0.94 | -$2.43 | -$0.78 | -$0.74 | -$1.01 | -$1.50 | -$1.86 | -$2.62 |
| Free cash flow | -83 | -152 | -46 | -93 | -57 | -28 | -38 | -26 | -26 | -44 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LAB in Markets.
See also: LAB valuation and P/E history · LAB returns
No forecast, no recommendation. This page describes Standard Biotools Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.